Heart Disease Clinical Trials in North Carolina

Showing 161-180 of 248 trials

Cooperative Lifestyle Programs (CLIP-II)

NCT01547182

The aim is to study the effects of weight loss and weight loss combined with different types of physical activity on changes in physical functioning of older adults who are at-risk for cardiovascular disease.

Cardiovascular DiseaseObesityPhysical Disability

Wake Forest University Health Sciences249 participantsStarted Mar 2012

Kernersville, North Carolina, United States • Winston-Salem, North Carolina, United States • Winston-Salem, North Carolina, United States

TERMINATEDPHASE438 miles

Naltrexone/Bupropion Cardiovascular Outcomes Study

NCT02638129

The purpose of this study is to evaluate cardiovascular (CV) safety of naltrexone hydrochloride (HCl) and bupropion HCl extended release combination (NB) compared with placebo and rule out excess risk of major adverse cardiovascular events (MACE) when given in combination with standard of care in overweight and obese participants with documented history of CV disease.

ObesityCardiovascular Diseases

Orexigen Therapeutics, Inc67 participantsStarted Jan 2016

Alexander City, Alabama, United States • Auburn, Alabama, United States • Birmingham, Alabama, United States +136 more locations

Cooperative Lifestyle Programs (CLIP-II)

Naltrexone/Bupropion Cardiovascular Outcomes Study

Heart Disease Trials in Other Cities

Prospective Aerobic Reconditioning Intervention Study

Effect of Pexelizumab on All-Cause Mortality and Myocardial Infarction in Patients Undergoing Coronary Artery Bypass Graft Surgery With Cardio-Pulmonary Bypass

Targeting Acute Congestion With Tolvaptan in Congestive Heart Failure

Get Going: Accelerometer-Based Intervention to Promote Physical Activity in Frail Older Adults

Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study

Cardiovascular Improvements With MV ASV Therapy in Heart Failure

Echocardiography Guided Cardiac Resynchronization Therapy (EchoCRT)

Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)

Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)

Clinician Utilization of Corus CAD (or ASGES) in Primary Care Provider Decision Making

Extension Phase of the Chronicle® Offers Management to Patients With Advanced Signs & Symptoms of Heart Failure Study

NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation

Prospective Multicenter Registry On RadiaTion Dose Estimates Of Cardiac CT AngIOgraphy IN Daily Practice in 2017

Sapphire II PRO US Clinical Study

Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease

An Assessment of the Glider Balloon in Complex Lesions

Combination Therapy Compared With Single-Drug Therapy in Patients With Cardiac Diseases

Pharmacist-led Group Medical Visits to Help With Diabetes Management

Other Conditions in North Carolina